3 Cheap Surgical Stocks to Buy Now Before They Bounce Back
The global pandemic has devastated orthopedic companies that manufacture hip, knee, shoulder, and dental replacements. The elective surgeries that use these healthcare products have mostly been put on hold during the COVID-19 pandemic.
Shares in Smith+Nephew (NYSE: SNN), Zimmer Biomet (NYSE: ZBH), and Stryker (NYSE: SYK) are all down more than 10% year to date. All three have suspended their 2020 guidance. The doom and gloom of their most recent quarterly reports have helped keep share prices down.
Assuming the global pandemic isn't with us forever, this may be the best time to pounce on these companies. Their long-term growth possibilities remain upbeat. One study puts the orthopedic implants market at $68.2 billion in global revenue by 2026.
Source Fool.com
